Your English writing platform
Discover LudwigSuggestions(1)
Exact(49)
Tiagabine monotherapy in the treatment of partial epilepsy.
Furthermore, perampanel has been approved in over 40 countries as an adjunctive therapy for the treatment of partial seizures with or without secondary generalization28.
Oxcarbazepine is a drug that is approved as monotherapy for the treatment of partial seizures and generalized tonic clonic seizures.
To evaluate the safety and efficacy of several different Morcher iris diaphragms in the treatment of partial or complete aniridia.
Perampanel is a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA) antagonist that has been approved for the treatment of partial seizures.
Treatment of partial hearing loss with the combined electrical and acoustical stimulation (EAS) aims at restoring the hearing while preserving the residual hearing.
Similar(11)
Despite the limitations of the open-label study design, these data provide information regarding the use of levetiracetam as add-on therapy for the treatment of partial-onset seizures in patients ⩾65 years of age, including those requiring concomitant medications.
Topiramate is an antiepileptic drug, which has been approved by the FDA in the United States and in many other countries for the preventive treatment of migraine in adults and for the treatment of partial-onset seizures and primary generalized tonic clonic seizures as add-on therapy in children as young as 2 years.
Retigabine, the best described of these, is now in clinical trials phase III for the treatment of partial-onset seizures.
One such compound is perampanel; it is a drug recently approved by FDA for treatment of partial-onset seizures.
It is a first-in-class AED approved for adjunctive treatment of partial-onset seizure in patients aged 12 years or older.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com